‌

US Patent 10806730 Methods of treating cancer with farnesyltransferase inhibitors

Patent 10806730 was granted and assigned to Kura Oncology, Inc. on October, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Kura Oncology, Inc.

Current Assignee

Kura Oncology, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

108067300

Date of Patent

October 20, 2020

Patent Application Number

158199640

Date Filed

November 21, 2017

Patent Citations Received

‌

US Patent 11291663 Methods of treating cancer with farnesyltransferase inhibitors

Patent Primary Examiner

‌

Jeffrey S Lundgren

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10806730 Methods of treating cancer with farnesyltransferase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API